Brief: Faron Pharmaceuticals H1 Operating Loss Narrows To EUR 11.3 Mln
Aug 27 (Reuters) - Faron Pharmaceuticals Oy FARN.L :
* HALF-YEAR FINANCIAL RESULTS
* CASH BALANCES OF EUR 30.0 MILLION ON JUNE 30, 2024 (2023:
EUR
6.3 MILLION)
* OPERATING LOSS OF EUR 11.3 MILLION FOR SIX MONTHS ENDED
JUNE 30,
2024 (2023: EUR 12.8 MILLION)
Source text for Eikon: ID:nWkr1jdxTz
Further company coverage: FARN.L
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Faron Pharmaceuticals Oy
See all newsFaron Pharmaceuticals: Faron to Report Final Melanoma Survival Data from the MATINS Study at ESMO 2026
Faron Pharmaceuticals: Composition of Faron Pharmaceutical’s Shareholders’ Nomination Board
Convertible bond amortization payment deferred by mutual agreement with HCM
Issuance of warrants
HOLDING(S) IN COMPANY